TrialJournal of hematology & oncology2021

Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials.

Keshu Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.